---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-005435"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2023-02-17T23:59:59+00:00"
generated_at: "2026-06-19T08:07:34.730705+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AgeX Therapeutics draws $1M under amended convertible note with Juvenescence; issues warrants for 801,924 shares

## Summary
- On Feb 15, 2023, drew $1M under Amended Secured Convertible Note with Juvenescence Limited.
- Up to $2M additional available until May 9, 2023; each draw limited to $1M and subject to Juvenescence's approval.
- Warrants for 801,924 shares at exercise price of $0.6235 per share issued in connection with the draw.
- Repayment date unchanged at Feb 14, 2024; note secured by security interests in AgeX assets.

## SEC filing metadata
- accession: 0001493152-23-005435
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2023-02-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/0001493152-23-005435-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-005435
- JSON: https://secwatch.observer/filing/0001493152-23-005435.json
- Plain text: https://secwatch.observer/filing/0001493152-23-005435.txt

## Key facts
- Debt Financings
  Serina Therapeutics, Inc. incurred senior notes of $1 million with Juvenescence Limited maturing February 14, 2024.
  - Instrument: senior notes
  - Principal: $1 million
  - Counterparty: Juvenescence Limited
  - Maturity: February 14, 2024
  - Event: incurrence
  source text: On February 15, 2023, AgeX drew $1 million of its available credit under the Amended and Restated Secured Convertible Promissory Note (“Amended Note”) dated February 9, 2023 with Juvenescence Limited (“Juvenescence”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/0001493152-23-005435-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.